Advertisement

Topics

Levi Strauss & Co. Company Profile

17:15 EDT 24th September 2017 | BioPortfolio

Levi Strauss & Co. is one of the world’s largest branded apparel companies and the global leader in jeanswear, marketing its products in more than 110 countries worldwide. The company designs and markets jeans, casual wear and related accessories for men, women and children under the Levi’s®, Dockers® and Signature by Levi Strauss & Co.™ brands. Levi Strauss & Co. reported fiscal 2008 net revenues of $4.4 billion. For more information, go to http://levistrauss.com.


News Articles [73 Associated News Articles listed on BioPortfolio]

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc.

NEW YORK, NY / ACCESSWIRE / May 8, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of INSYS Therapeut...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ImmunoCellular Therapeutics, Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 30, 2017 - IMUC

NEW YORK, NY / ACCESSWIRE / May 26, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCell...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dr. Reddy's Laboratories Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY

NEW YORK, NY / ACCESSWIRE / September 19, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr. ...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Foundation Medicine, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI

NEW YORK, NY / ACCESSWIRE / August 23, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Foundat...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Foundation Medicine, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI

NEW YORK, NY / ACCESSWIRE / August 25, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Foundat...

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SV

NEW YORK, NY / ACCESSWIRE / August 11, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Foundation Medicine, Inc. Shareholders of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2017 - FMI

NEW YORK, NY / ACCESSWIRE / September 19, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Foun...

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA

NEW YORK, NY / ACCESSWIRE / August 2, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sinovac ...

Drugs and Medications [0 Results]

None

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Reply to Levi et al.

Applicability of the Therapeutic Nursing Theory in Neurological (Early-) Rehabilitation into Nursing Practice - A Case Study.

Purpose The objective of the study is to describe how the theory of therapeutic nursing in neurological (early) rehabilitation can be transferred into nursing practice. Materials and Methods The theor...

ANCA-associated vasculitides at Mexico City's metropolitan Eastern area.

The anti-neutrophil cytoplasmic antibody-associated (ANCA) vasculitides includes granulomatosis with polyangiitis (Wegener's) (GPW), Chrug-Strauss syndrome (CSS) and microscopic polyangiitis (MPA). Si...

Cannabis use and dating violence among college students: A call for research.

Dating violence is a serious and prevalent problem on college campuses. Although there is a robust literature documenting that alcohol use is consistently associated with increased risk for perpetrati...

ANCA Glomerulonephritis and Vasculitis.

ANCA vasculitis has an associated autoimmune response that produces ANCAs that induce distinct pathologic lesions. Pauci-immune necrotizing and crescentic GN is a frequent component of ANCA vasculitis...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain

This is a first-in-human, phase 1, single centre, placebo-controlled, double-blind, single ascending dose study of LEVI-04 in heathy volunteers and osteoarthritis patients (with pain attri...

Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome

The purpose of this study is to determine whether Mepolizumab (a monoclonal antibody against interleukin-5) is a safe and well-tolerated therapy that will allow for steroid tapering in pat...

Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

Churg-Strauss syndrome is a rare type of systemic vasculitis which occurs almost exclusively in patients with asthma and which is characterized by prominent blood and tissue eosinophilia. ...

Rituxan in Churg Strauss Syndrome

A pilot, open label study using 4 weekly doses of Rituximab in the treatment of CSS with renal involvement.

Eosinophilic Granulomatosis With Polyangiitis Cohort

EGPA (Eosinophilic Granulomatosis with Polyangiitis, previously Churg-Strauss syndrome) is a rare vasculitis, characterised by asthma, rhinosinusitis and eosinophilia. There has previously...

Companies [9 Associated Companies listed on BioPortfolio]

Levi Strauss & Co.

Levi Strauss & Co. is one of the world’s largest branded apparel companies and the global leader in jeanswear, marketing its products in more than 110 countries worldwide. Th...

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to...

FGX International Holdings Limited

FGX International Holdings Limited is a leading designer and marketer of non-prescription reading glasses and sunglasses with a portfolio of established, highly recognized eyewear...

LEVI . COM

Nil

Levi & Korsinsky, LLP

More Information about "Levi Strauss & Co." on BioPortfolio

We have published hundreds of Levi Strauss & Co. news stories on BioPortfolio along with dozens of Levi Strauss & Co. Clinical Trials and PubMed Articles about Levi Strauss & Co. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Levi Strauss & Co. Companies in our database. You can also find out about relevant Levi Strauss & Co. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...


Corporate Database Quicklinks



Searches Linking to this Company Record